Literature DB >> 16102576

The repair of DNA damages/modifications during the maturation of the immune system: lessons from human primary immunodeficiency disorders and animal models.

Patrick Revy1, Dietke Buck, Françoise le Deist, Jean-Pierre de Villartay.   

Abstract

The immune system is the site of various genotoxic stresses that occur during its maturation as well as during immune responses. These DNA lesions/modifications are primarily the consequences of specific physiological processes such as the V(D)J recombination, the immunoglobulin class switch recombination (CSR), and the generation of somatic hypermutations (SHMs) within Ig variable domains. The DNA lesions can be introduced either by specific factors (RAG1 and RAG2 in the case of V(D)J recombination and AID in the case of CSR and SHM) or during the various phases of cellular proliferation and cellular activation. All these DNA lesions are taken care of by the diverse DNA repair machineries of the cell. Several animal models as well as human conditions have established the critical importance of these DNA lesions/modifications and their repair in the physiology of the immune system. Indeed their defects have consequences ranging from immune deficiency to development of immune malignancy. The survey of human pathology has been highly instrumental in the past in identifying key factors involved in the generation of DNA modifications (AID for the Ig CSR and generation of SHM) or the repair of specific DNA damages (Artemis for V(D)J recombination). Defects in factors involved in the cell cycle checkpoints following DNA damage also have deleterious consequences on the immune system. The continuous survey of human diseases characterized by primary immunodeficiency associated with increased sensitivity to ionizing radiation should help identify other important DNA repair factors essential for the development and maintenance of the immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102576     DOI: 10.1016/S0065-2776(05)87007-5

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  22 in total

1.  Rad9 is required for B cell proliferation and immunoglobulin class switch recombination.

Authors:  Lili An; Yulan Wang; Yuheng Liu; Xiao Yang; Chunchun Liu; Zhishang Hu; Wei He; Wenxia Song; Haiying Hang
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  Structural characterization of filaments formed by human Xrcc4-Cernunnos/XLF complex involved in nonhomologous DNA end-joining.

Authors:  Virginie Ropars; Pascal Drevet; Pierre Legrand; Sonia Baconnais; Jeremy Amram; Guilhem Faure; José A Márquez; Olivier Piétrement; Raphaël Guerois; Isabelle Callebaut; Eric Le Cam; Patrick Revy; Jean-Pierre de Villartay; Jean-Baptiste Charbonnier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

Review 3.  XLF/Cernunnos: An important but puzzling participant in the nonhomologous end joining DNA repair pathway.

Authors:  Vijay Menon; Lawrence F Povirk
Journal:  DNA Repair (Amst)       Date:  2017-08-18

4.  Cryo-EM structure of human DNA-PK holoenzyme.

Authors:  Xiaotong Yin; Mengjie Liu; Yuan Tian; Jiawei Wang; Yanhui Xu
Journal:  Cell Res       Date:  2017-08-25       Impact factor: 25.617

Review 5.  The MRE11 complex: starting from the ends.

Authors:  Travis H Stracker; John H J Petrini
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02       Impact factor: 94.444

6.  The human LINE-1 retrotransposon creates DNA double-strand breaks.

Authors:  Stephen L Gasior; Timothy P Wakeman; Bo Xu; Prescott L Deininger
Journal:  J Mol Biol       Date:  2006-02-09       Impact factor: 5.469

7.  Lymphopoiesis in transgenic mice over-expressing Artemis.

Authors:  P Rivera-Munoz; V Abramowski; S Jacquot; P André; S Charrier; K Lipson-Ruffert; A Fischer; A Galy; M Cavazzana; J-P de Villartay
Journal:  Gene Ther       Date:  2015-10-01       Impact factor: 5.250

Review 8.  Role of non-homologous end joining in V(D)J recombination.

Authors:  Shruti Malu; Vidyasagar Malshetty; Dailia Francis; Patricia Cortes
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

9.  Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model.

Authors:  Alessia Balestrini; Laura Nicolas; Katherine Yang-Lott; Olga A Guryanova; Ross L Levine; Craig H Bassing; Jayanta Chaudhuri; John H J Petrini
Journal:  Mol Cancer Res       Date:  2015-11-04       Impact factor: 5.852

10.  A biochemically defined system for coding joint formation in V(D)J recombination.

Authors:  Haihui Lu; Noriko Shimazaki; Prafulla Raval; Jiafeng Gu; Go Watanabe; Klaus Schwarz; Patrick C Swanson; Michael R Lieber
Journal:  Mol Cell       Date:  2008-08-22       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.